Drugs & Targets European Commission Approves Unituxin In Pediatric High-Risk Neuroblastoma August 31, 2015Vol.38 No.08
Drugs & TargetsFree Mirati Therapeutics and MedImmune launch clinical trial collaboration August 07, 2015Vol.41 No.31
Drugs & TargetsFree AstraZeneca and Heptares Therapeutics enter licensing agreement August 07, 2015Vol.41 No.31
Drugs & TargetsFree Health Canada Approves Imbruvica In Mantle Cell Lymphoma August 07, 2015Vol.41 No.31
Drugs & Targets FDA Approves Odomzo in Advanced BCC, Kyprolis Combination in Multiple Myeloma August 04, 2015Vol.38 No.07
Drugs & TargetsFree Lenvima Receives Breakthrough Therapy Designation from FDA July 30, 2015Vol.41 No.30
